HBV感染免疫耐受期产妇与正常产妇脐带血浆细胞样树突状细胞中PI3K、mTOR、p70S6K、IFNα的表达情况分析

杨雯珺; 霍燚; 彭建平

doi:10.3969/j.issn.1001-5256.2020.08.010

HBV感染免疫耐受期产妇与正常产妇脐带血浆细胞样树突状细胞中PI3K、mTOR、p70S6K、IFNα的表达情况分析

DOI: 10.3969/j.issn.1001-5256.2020.08.010

1. 湖南中医药大学
2. 湖南中医药大学第一附属医院肝病科

基金项目:

国家自然科学基金项目(8170151973)；

详细信息

中图分类号: R714.251
计量
- 文章访问数: 1252
- HTML全文浏览量: 26
- PDF下载量: 124
- 被引次数: 0
出版历程
- 出版日期: 2020-08-20

Expression of phosphoinositide 3-kinase,mammalian target of rapamycin,70-k Da ribosomal protein S6 kinase,and interferon-α in umbilical cord blood plasmacytoid dendritic cells in parturients in the immune tolerance stage of hepatitis B virus infection versus normal parturients

Hunan University of Chinese Medicine

Research funding:

摘要

摘要:
目的比较HBV感染免疫耐受期产妇脐带血与正常产妇脐带血浆细胞样树突状细胞（pDC）中PI3K、mTOR、p70S6K、IFNα表达的差异。方法选取湖南中医药大学第一附属医院产科住院部2017年10月-2020年1月HBV感染免疫耐受期产妇20例(乙型肝炎组)及正常产妇10例（正常组）。分离培养脐带血pDC，在培养的第7天加入CpG-A，24 h后分别收集细胞及上清液，real-time PCR检测pDC PI3K、mTOR、p70S6K mRNA的表达，Western Blot技术检测pDC PI3K、mTOR、p70S6K蛋白表达，ELISA法检测pDC 培养上清IFNα水平。计量资料采用两独立样本t检验。结果乙型肝炎组HBV感染免疫耐受期产妇脐带血pDC PI3K、mTOR、p70S6K mRNA表达水平显著低于正常产妇组（t值分别为-81.04、-63.07、-34.55，P值均＜0.001）；乙型肝炎组HBV感染免疫耐受期产妇脐带血pDC PI3K、mTOR、p70S6K 蛋白表达水平亦显著低于正常产妇组（t值分别为-8.13、-7.75、-6.71，P值均＜0.001）；乙型肝炎组HBV感染免疫耐受期产妇脐带血pDC培养上清IFNα表达水平显著低于正常产妇组（t=-15.88，P＜0.05）。结论HBV感染免疫耐受期产妇脐带血pDC的PI3K、mTOR、p70S6K mRNA和蛋白表达水平及IFNα水平减少，pDC功能受到抑制。
- 乙型肝炎病毒 /
- 树突细胞 /
- 磷酸肌醇3-激酶 /
- TOR丝氨酸-苏氨酸激酶 /
- 核糖体蛋白质S6激酶类,70-kDa
Abstract:
Objective To investigate the expression of phosphoinositide 3-kinase(PI3 K),mammalian target of rapamycin(m TOR),70-k Da ribosomal protein S6 kinase(p70 S6 K),and interferon-α(IFNα) in umbilical cord blood plasmacytoid dendritic cells(p DCs)in parturients in the immune tolerance stage of hepatitis B virus(HBV) infection versus normal parturients.Methods A total of 20 parturients in the immune tolerance stage of HBV infection and 10 normal parturients who were hospitalized in Inpatient Department of Obstetrics in The First Affiliated Hospital of Hunan University of Chinese Medicine from October 2017 to January 2020 were enrolled as hepatitis B group and normal group,respectively.Umbilical cord blood pDCs were isolated and cultured,and CpG-A was added on day 7.The cells and the supernatant were collected after 24 hours;real-time PCR was used to measure the mRNA expression of PI3 K,m TOR,and p70 S6 K,Western Blot was used to measure the protein expression of PI3 K,m TOR,and p70 S6 K,and ELISA was used to measure the level of IFNα in the supernatant of p DCs.The two-independent-samples t-test was used for comparison of continuous data between the two groups.Results Compared with the normal group,the hepatitis B group had significantly lower mRNA and protein expression of PI3 K,m TOR,and p70 S6 K in umbilical cord blood p DCs(mRNA expression:t=-81.04,-63.07,and-34.55,all P<0.001;protein expression:t=-8.13,-7.75,and-6.71,all P<0.001).The hepatitis B group had significantly lower expression of IFNα in the supernatant of umbilical cord blood p DCs than the normal group(t=-15.88,P<0.05).Conclusion Parturients in the immune tolerance stage of HBV infection have reductions in the mRNA and protein expression of PI3 K,m TOR,and p70 S6 K and the level of IFNα in umbilical cord blood pDCs,suggesting that pDC function is inhibited.
- hepatitis B virus /
- dendritic cells /
- phosphatidylinositol 3-kinase /
- TOR serine-threonine kinases /
- ribosomal protein S6 kinases,70-kDa

HTML全文

参考文献(24)

[1] WHO. Global hepatitis report,2017[EB/OL].[2019-11-06]. https://www. who. int/hepatitis/publications/globalhepatitis-report2017/en/．

[2] GE JB,XU YJ. Internal Medicine 8th edition[M]. Beijing:People’s Medical Publishing House,2018.(in Chinese)葛均波，徐永健．内科学(第8版)[M]．北京:人民卫生出版社，2018.

[3] KUSHNER T,SARKAR M. Chronic hepatitis B in pregnancy[J]. Clin Liver Dis,2018,12(1):24.

[4] TSE KY,HO LF,LAO T. The impact of maternal HBsAg carrier status on pregnancy outcomes:A case-control study[J]. J Hepatol,2005,43(5):771-775.

[5] SHAHEEN AAM,MYERS RP. The outcomes of pregnancy in patients with cirrhosis:A population-based study[J]. Liver Int,2010,30(2):275-283.

[6] ALLWEISS L,DANDRI M. The role of cccDNA in HBV maintenance[J]. Viruses,2017,9(6):156.

[7] GAO HY,LIU N,LU RZ,et al. Research progress on immune tolerance in chronic HBV infection[J]. Chin Hepatol,2017,22(9):848-850.(in Chinese)高红艳，刘娜，卢荣增，等．慢性HBV感染免疫耐受的研究进展[J]．肝脏，2017,22(9):848-850.

[8] LAI SM,LAI XL,HUANG X,et al. Meta-analysis of nucleoside(acid)analogs treated with sequential pegylated interferon for chronic hepatitis B[J]. Chin J Infect Chemother,2019,19(5):489-494.(in Chinese)赖思敏，赖小丽，黄汐，等．核苷(酸)类似物经治序贯聚乙二醇干扰素治疗慢性乙型肝炎的荟萃分析[J]．中国感染与化疗杂志，2019,19(5):489-494.

[9] REIZIS B. Plasmacytoid dendritic cells:Development,regulation,and function[J]. Immunity,2019,50(1):37-50.

[10] CAO W,MANICASSAMY S,TANG H,et al. Tol-like receptormediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-m TOR-p70S6K pathway[J]. Nat immunol,2008,9(10):1157.

[11] Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese,Medical Association. The guideline of prevention and treatment for chronic hepatitis B(2015 Update)[J]. J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会，中华医学会感染病学分会．慢性乙型肝炎防治指南(2015年更新版)[J]．临床肝胆病杂志，2015,31(12):1941-1960.

[12] PENG JP,SUN KW,YIN SS,et al. In vitro induction and identification of human umbilical cord plasma-like dendritic cell subsets[J]. J Clin Hepatol,2015,31(11):1862-1866.(in Chinese)彭建平，孙克伟，银丝丝，等．人脐带血浆细胞样树突状细胞亚群的体外诱导及鉴定[J]．临床肝胆病杂志，2015,31(11):1862-1866.

[13] CUI TP. Cytokines and immunological tests[M]. Beijing:People’s Medical Publishing House,2018.(in Chinese)崔天盆．细胞因子及免疫学检验[M]．北京:人民卫生出版社，2018.

[14] XIE Q,SHEN HC,JIA NN,et al. Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9[J]. Microbes Infect,2009,11(4):515-523.

[15] MACAL M,JO Y,DALLARI S,et al. Self-renewal and tolllike receptor signaling sustain exhausted plasmacytoid dendritic cells during chronic viral infection[J]. Immunity,2018,48(4):730-744. e5.

[16] PENG JP,SUN KW,YIN SH,et al. Effects of HBV on toll-like receptor 9,interferon regulatory factor 7,interferon alpha expression in umbilical cord plasma-like dendritic cells of healthy maternity[J]. J Clin Hepatol,2016,32(5):894-898.(in Chinese)彭建平，孙克伟，银思涵，等．HBV对健康产妇脐带血浆细胞样树突状细胞Toll样受体9，干扰素调节因子7，干扰素α表达的影响[J]．临床肝胆病杂志，2016,32(5):894-898.

[17] CHAMCHEU JC,ROY T,UDDIN MB,et al. Role and therapeutic targeting of the PI3K/Akt/m TOR signaling pathway in skin cancer:A review of current status and future trends on natural and synthetic agents therapy[J]. Cel s,2019,8(8):803.

[18] van MONTFORT T,van der SLUIS R,DARCIS G,et al. Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation,activating the PI3K-Akt-m TOR pathway[J]. EBio Medicine,2019,42:97-108.

[19] XIANG K,WANG B. Role of the PI3K-AKT-m TOR pathway in hepatitis B virus infection and replication[J]. Mol Med Rep,2018,17(3):4713-4719.

[20] TANG YY,TANG ZH,ZHANG Y,et al. The fusion protein of CTP-HBcAg18-27-Tapasin mediates the apoptosis of CD8(+)T cells and CD8(+)T cell response in HLA-A2 transgenic mice[J]. Hepat Mon,2014,14(2):e16161.

[21] WOLTMAN AM,BOONSTRA A,JANSSEN HLA. Dendritic cells in chronic viral hepatitis B and C:Victims or guardian angels?[J].Gut,2010,59(1):115-125.

[22] UEDA Y,HAGIHARA M,OKAMOTO A,et al. Frequencies of dendritic cells(myeloid DC and plasmacytoid DC)and their ratio reduced in pregnant women:Comparison with umbilical cord blood and normal healthy adults[J]. Hum Immunol,2003,64(12):1144-1151.

[23] JIANG H,WADE-HARRIS C,BAXI L,et al. Significant decrease in cord blood(CB)versus adult peripheral blood(APB)monocyte(Mo)–derived dendritic cell(DC)gene and protein expression patterns and T cell functional activation:Insight into immaturity of CB cellular immunity[J]. Biol Blood Marrow Tr,2006,12(2):52-53.

[24] WOLTMAM AM,DEN BROUW MLO,BIESTA PJ,et al. Hepatitis B virus lacks immune activating capacity,but actively inhibits plasmacytoid dendritic cell function[J]. PLo S One,2011,6(1):e15324.

施引文献

资源附件(0)

访问统计